Can sertraline cause blurred vision?

Can Sertraline Cause Blurred Vision?

Yes, sertraline can cause blurred vision, though this is not among its most common side effects. The FDA-approved prescribing information lists visual problems as a potential adverse effect requiring monitoring, and clinical evidence confirms ocular disturbances can occur with SSRI use 1, 2.

Evidence from FDA Labeling

The official FDA prescribing information for sertraline explicitly warns about visual problems, including 1:

• Eye pain
• Changes in vision
• Swelling or redness in or around the eye

The label specifically states that "only some people are at risk for these problems" and recommends patients may want to undergo an eye examination to assess risk and receive preventative treatment if indicated 1.

Mechanism and Clinical Context

How SSRIs Affect Vision

Sertraline and other SSRIs can cause visual disturbances through multiple mechanisms 2, 3:

• Mydriasis (pupil dilation) - Often transient with no major consequences, but can promote angle closure in susceptible patients 2
• Intraocular pressure (IOP) modifications - SSRIs have been shown to increase IOP in some patients, which may be asymptomatic in most cases but can lead to visual disturbances 3
• Acute angle-closure glaucoma - Rare but serious complication, particularly in predisposed eyes with narrow angles 2, 3

Frequency and Characteristics

While blurred vision is not listed among the most common side effects of sertraline (which primarily include gastrointestinal disturbances like nausea and diarrhea), visual disturbances do occur 4, 5:

• A small percentage of patients discontinue SSRIs due to "ill-defined visual disturbances" 3
• Unlike tricyclic antidepressants, which cause transient blurred vision in up to one-third of patients through accommodation problems, sertraline is generally "free of cardiac effects" and "does not cause hypotension, urinary retention or blurred vision" as commonly as older antidepressants 5
• However, this does not mean visual effects never occur—they are simply less frequent than with tricyclics 2

Clinical Monitoring Recommendations

Before Starting Sertraline

Ophthalmological consultation should be considered before starting sertraline in patients with glaucomatous risk factors, especially elderly patients 3. Specific risk factors to assess include:

• History of narrow-angle glaucoma or anatomically narrow angles
• Family history of glaucoma
• Advanced age
• Hyperopia (farsightedness)

During Treatment

If visual symptoms develop during sertraline therapy 1, 3:

1. Immediate evaluation needed for: Acute eye pain, sudden vision changes, seeing halos around lights, or red eye—these may indicate acute angle-closure glaucoma requiring emergency treatment
2. Routine monitoring for: Gradual or intermittent visual changes, which may represent sub-acute IOP elevation
3. Consider ophthalmology referral for any persistent visual complaints, even if seemingly minor

Important Caveats

• The incidence of SSRI-related IOP modifications is likely underestimated because most cases are asymptomatic or pauci-symptomatic (intermittent, sub-acute, or progressive angle-closure glaucoma) 3
• Visual disturbances are not a reason to avoid sertraline in most patients, as the overall tolerability profile remains favorable compared to older antidepressants 4, 5
• Sertraline has minimal anticholinergic activity compared to tricyclic antidepressants, making accommodation-related blurred vision less common 4

When to Discontinue

Sertraline should be discontinued if 1:

• Signs of acute angle-closure glaucoma develop (severe eye pain, vision changes, eye redness)
• Visual problems are accompanied by other signs of serious adverse effects (severe allergic reaction, serotonin syndrome)
• Visual disturbances are severe enough to impair function and persist despite evaluation

Do not stop sertraline abruptly—taper gradually to avoid discontinuation syndrome, which itself can include dizziness that may be confused with visual disturbance 1.